BLFS Q1 2022 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$36M+115.0% YoY

Gross Profit

$12M32.5% margin

Operating Income

-$11M-30.3% margin

Net Income

-$7M-19.5% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

-2.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$544M

Total Liabilities

$65M

Stockholders' Equity

$479M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$17M	+115.0%
Gross Profit	$12M	$9M	+26.6%
Operating Income	-$11M	-$981,000	-1016.9%
Net Income	-$7M	-$1M	-532.0%

Revenue Segments

Rental Revenue

$12M98%

Service Revenue

$205,0002%